About the journal
Hemato is an open-access journal published by MDPI AG in Switzerland, publishing in english. It is listed in DOAJ according to the sources read. Declared publication charge: 1,000 CHF. Declared review time at DOAJ: 11 weeks. Facts are reproduced as recorded at their sources with their capture dates; PublishLens indicators are available after sign-in.
Basic facts
- Publisher
- MDPI AG
- ISSN
- 2673-6357
- Country
- Switzerland
- Languages
- english
- Access
- Open access
- Declared publication charge
- 1,000 CHF
- Articles in DOAJ
- 230
- Declared review time
- 11 weeks
- Declared peer-review model
- peer_review
- Official website
- https://www.mdpi.com/journal/hemato
Index listings
- DOAJ · 2021-02-22
- Indexing
- DOAJ
- APC
- 1,000 CHF
- Declared review time (DOAJ)
- 11 weeks — journal-declared only (not measured)
- Activity (OpenAlex)
- Active — latest works 2026
- PublishLens list status
- Shown after sign-in
- Counts for promotion at your university?
- Choose your university and rank below ↓
Methodology signals (dated facts from their sources)
Details of the evaluation under the published methodology are shown to signed-in users (free).
Create a free account to view the evaluationJournal profile
Descriptive metadata from public sources (DOAJ, OpenAlex, PubMed) as of the capture date shown — contains no assessment or judgment.
Articles in DOAJ
230
Most recent article
3 months ago
Average review time (journal-declared via DOAJ)
11weeks
Works in OpenAlex
246
Last recorded publication year
2026
h-index
11
i10-index
18
From OpenAlex open data (CC0).
Editorial & policy13
- Last DOAJ review date
- 2023-04-12
- Added to DOAJ
- 2021-02-22
- Declared plagiarism screening
- Declared
- Other fees beyond APC
- No
- Declared digital preservation
- CLOCKSS
- Observed digital preservation (Keepers registry)— snapshot 2026-10-05
- CLOCKSS
- Editorial board
- Official page ↗
- Norwegian register (HK-dir)— 2026
- Level 1 — approved scholarly channel
- Open references deposited at Crossref
- 99%
- ORCID iDs in current deposits
- 91%
- Enrolled in Crossref Similarity Check
- ✓
- Deposits licence metadata at Crossref
- ✓
- APC waiver policy
- View policy
- Peer-review policy
- View policy
Identity & continuity1
- Source type
- journal
Classification2
Subjects (DOAJ)
LCC codes
Subject areas
- Lymphoma Diagnosis and Treatment
- Lymphoma Diagnosis and Treatment
- Chronic Lymphocytic Leukemia Research
- Chronic Lymphocytic Leukemia Research
- Acute Myeloid Leukemia Research
- Acute Myeloid Leukemia Research
- Multiple Myeloma Research and Treatments
- Multiple Myeloma Research and Treatments
Show all subjects (50)
- Chronic Myeloid Leukemia Treatments
- Myeloproliferative Neoplasms: Diagnosis and Treatment
- Myeloproliferative Neoplasms: Diagnosis and Treatment
- Chronic Myeloid Leukemia Treatments
- Acute Lymphoblastic Leukemia research
- Acute Lymphoblastic Leukemia research
- Hemoglobinopathies and Related Disorders
- Hemoglobinopathies and Related Disorders
- Amyloidosis: Diagnosis, Treatment, Outcomes
- Amyloidosis: Diagnosis, Treatment, Outcomes
- Viral-associated cancers and disorders
- Blood groups and transfusion
- Blood groups and transfusion
- Viral-associated cancers and disorders
- Hematopoietic Stem Cell Transplantation
- Hematopoietic Stem Cell Transplantation
- CAR-T cell therapy research
- CAR-T cell therapy research
- Protein Degradation and Inhibitors
- Protein Degradation and Inhibitors
- Iron Metabolism and Disorders
- Iron Metabolism and Disorders
- Erythrocyte Function and Pathophysiology
- Erythrocyte Function and Pathophysiology
- Immune Cell Function and Interaction
- Eosinophilic Disorders and Syndromes
- Peptidase Inhibition and Analysis
- Immune Cell Function and Interaction
- Eosinophilic Disorders and Syndromes
- Childhood Cancer Survivors' Quality of Life
- Peptidase Inhibition and Analysis
- CNS Lymphoma Diagnosis and Treatment
- Childhood Cancer Survivors' Quality of Life
- CNS Lymphoma Diagnosis and Treatment
- Neuroendocrine Tumor Research Advances
- Neuroendocrine Tumor Research Advances
- Venous Thromboembolism Diagnosis and Management
- Venous Thromboembolism Diagnosis and Management
- COVID-19 Clinical Research Studies
- Platelet Disorders and Treatments
- COVID-19 Clinical Research Studies
- Platelet Disorders and Treatments
Keywords (DOAJ)
- lymphoid leukemias
- immunogenetics
- non neoplastic blood disorders
- transplantation
- target therapy
- immunobiology
Community confirmations — what users saw in MJL or Scopus Sources; not platform verification and never part of any score.
The journal's record in other sources:Web of Science MJLDOAJ